Central Nervous System (CNS) Therapeutics Market Size, Share, Growth and Industry Report

<p>The global central nervous system (CNS) therapeutics market size reached USD 148.7 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 257.3 Billion by 2033, exhibiting a growth rate (CAGR) of 5.64% during 2025-2033. The growing prevalence of neurological and psychiatric disorders among the masses, the rise in telehealth and telemedicine services, and the increase in trade agreements and partnerships are among the key factors driving the market growth.</p>

<table align="center" border="1" cellpadding="1" cellspacing="1" dir="ltr" style="width:100%">
<thead>
<tr>
<th scope="col" style="width:70%">
<div style="text-align:left"><strong>Report Attribute</strong></div>
</th>
<th scope="col">
<div>Key Statistics</div>
</th>
</tr>
</thead>
<tbody>
<tr>
<td>
<div><strong>Base Year</strong></div>
</td>
<td>2024</td>
</tr>
<tr>
<td>
<div><strong>Forecast Years</strong></div>
</td>
<td>
<div>2025-2033</div>
</td>
</tr>
<tr>
<td>
<div><strong>Historical Years</strong></div>
</td>
<td>
<div>2019-2024</div>
</td>
</tr>
<tr>
<td><strong>Market&nbsp;Size in 2024</strong></td>
<td>USD 148.7 Billion</td>
</tr>
<tr>
<td><strong>Market Forecast in 2033</strong></td>
<td>USD 257.3 Billion</td>
</tr>
<tr>
<td><strong>Market&nbsp;Growth Rate&nbsp;2025-2033</strong></td>
<td>5.64%</td>
</tr>
</tbody>
</table>

<p>IMARC Group provides an analysis of the key trends in each segment of the central nervous system (CNS) therapeutics market report, along with forecasts at the global, regional and country levels for 2025-2033. Our report has categorized the market based on disease and application.</p>

<p>全球中枢神经系统（CNS）治疗药物市场规模于2024年达到1487亿美元。展望未来，IMARC集团预计，至2033年，该市场规模将增至2573亿美元，在2025年至2033年期间呈现5.64%的复合年增长率。民众中神经和精神疾病的日益普遍、远程医疗和远程医疗服务的发展，以及贸易协议和合作的增加，是推动市场增长的主要因素。</p>

<table align="center" border="1" cellpadding="1" cellspacing="1" dir="ltr" style="width:100%">
<thead>
<tr>
<th scope="col" style="width:70%">
<div style="text-align:left"><strong>报告属性</strong></div>
</th>
<th scope="col">
<div>关键统计数据</div>
</th>
</tr>
</thead>
<tbody>
<tr>
<td>
<div><strong>基准年</strong></div>
</td>
<td>2024</td>
</tr>
<tr>
<td>
<div><strong>预测年</strong></div>
</td>
<td>
<div>2025-2033</div>
</td>
</tr>
<tr>
<td>
<div><strong>历史年</strong></div>
</td>
<td>
<div>2019-2024</div>
</td>
</tr>
<tr>
<td><strong>2024年市场规模</strong></td>
<td>1487亿美元</td>
</tr>
<tr>
<td><strong>2033年市场规模预测</strong></td>
<td>2573亿美元</td>
</tr>
<tr>
<td><strong>2025-2033年市场增长率</strong></td>
<td>5.64%</td>
</tr>
</tbody>
</table>

<p>IMARC集团对本报告中枢神经系统（CNS）治疗药物市场的各个细分市场关键趋势进行了分析，并就2025-2033年全球、区域和国家层面的预测进行了阐述。本报告根据疾病和应用对市场进行了分类。</p>